Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...

We've rounded up all of this week's best iPhone 15 deals into one easy to navigate list right here. Using this page, you'll easily be able to compare all your options at the big carriers ...

When it comes to laptop screen sizes, I really like 15 inches because it offers a nice midpoint between portability and big-screen luxury. And the best 15-inch laptops straddle that line perfectly ...

The various trials covered time periods ranging from 40 to 52 weeks and included three different strengths of Mounjaro: 5 mg, 10 mg, and 15 mg. The primary endpoint for all the SURPASS trials was ...

(Image Credits: Pexel) A new study has revealed that off-label use of semaglutide (Ozempic) and tirzepatide (Mounjaro) leads to significant reductions in HbA1c levels and body weight among adults ...

(Reuters) -Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico in 2025, Chief Financial Officer Lucas Montarce said on Monday at the ...

Weight loss drugs like Ozempic, Mounjaro, and Zepbound have changed millions ... But after eight weeks on a 1.5 mg dose, he woke up one morning unable to see clearly. He was diagnosed with NAION.